About Royalty Pharma plc

Royalty Pharma plc (NASDAQ: RPRX) is a Healthcare company (Medical - Pharmaceuticals) with a market capitalization of $27.7B. Its Maz Rating is 4.51 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 2.31, Growth 3.75, Profitability 4.92, Financial Health 2.43, Momentum 4.31 (as of 2026-10-16).

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Exchange

NASDAQ

Country

US

CEO

Pablo Legorreta

Employees

100

IPO date

2020-06-16